Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office

• 主要な著者: Diego Alejandro Dri (著者), Elisa Gaucci (著者), Ilaria Torrieri (著者), Maria Carafa (著者), Carlotta Marianecci (著者), Donatella Gramaglia (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2022-07-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Investigational medicinal products submitted over the course of 3 years and authorized at the Clinical Trials Office of the Italian Medicines Agency as part of a request for authorization of clinical trials were scrutinized to identify those encompassing nanomedicines. The quality assessment reports...